GENE has been trading like the float is locked for days. Projected profits are around $12 p/share. Speculators are thinking it'll be either be bought out or have several monster beats over the next couple of quarters. Of course shorts (or share poor) talk about dilution. Doesn't make sense to me to dilute at $4 when you'll be at $7 next month, but it also don't make sense to me to short a 3 mill float stock that trades over 3 million, so no telling. It's just a typical low floater with a ton of volume until we get some real numbers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.